respiratory syncytial virus vaccine (bivalent, recombinant) · Medicine question

What do data from more than 4,000 exposed pregnancy outcomes indicate about malformations and fetal or neonatal toxicity with Abrysvo?

Name: What do data from more than 4,000 exposed pregnancy outcomes indicate about malformations and fetal or neonatal toxicity with Abrysvo?
Published: 2026-11-08T14:29:25.792Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

Data from more than 4,000 exposed pregnancy outcomes indicate no malformative or fetal/neonatal toxicity with Abrysvo.

Sources for this answer

Abrysvo powder and solvent for solution for injectionPfizer Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 13Document updated 4 June 2026

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about respiratory syncytial virus vaccine (bivalent, recombinant)